Edwards Lifesciences (EW) Other Operating Expenses (2017 - 2026)

Edwards Lifesciences has reported Other Operating Expenses for 5 years, with the latest figure at $14.2 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses fell 25.65% year-over-year to $14.2 million; the trailing twelve-month figure through Mar 2026 stood at $62.3 million (up 221.13% YoY), and the FY2025 full-year result was $67.2 million, up 22300.0% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $14.2 million, down from $14.3 million in the prior quarter.
• The five-year high for Other Operating Expenses was $22.7 million in Q4 2024, with the low at -$22.4 million in Q3 2024.
• Average Other Operating Expenses over 3 years is $11.7 million, with a median of $14.3 million recorded in 2025.
• Peak annual rise in Other Operating Expenses reached 155.8% in 2025, while the deepest fall reached 37.0% in 2025.
• Tracing EW's Other Operating Expenses over 3 years: stood at $22.7 million in 2024, then tumbled by 37.0% to $14.3 million in 2025, then dropped by 0.7% to $14.2 million in 2026.
• The last three Other Operating Expenses figures came in at $14.2 million (Q1 2026), $14.3 million (Q4 2025), and $12.5 million (Q3 2025), per Business Quant data.

Peer Comparison